Umami Seed Co. is preparing to enter Australia’s medicinal cannabis market through a partnership with Austranna. With award-winning genetics and plans to introduce YEET to Australian and European markets, the opportunity is significant. But the real test will be whether local cultivation, post-harvest handling and consistency can deliver finished flower that lives up to the reputation of Umami’s genetics.

Wizard Trees will become the presenting sponsor of Mary Jane Berlin 2027, marking another major step in the brand’s international growth. Five years after committing to its own genetics programme, Wizard Trees lines are now being worked around the world, from Europe to New Zealand. The sponsorship shows how far a California genetics and flower brand has expanded beyond its original market.

For decades, the runner’s high was largely credited to endorphins. Research into anandamide, 2-AG and the endocannabinoid system is revealing a much more complex story. From running and cycling to surfing and sustained training, exercise can alter cannabinoid signalling in ways that may influence mood, anxiety, pain and reward.

U.S. Government Shutdown Cannabis Impact stalls reform, freezes research, and could strip $1–3B from industry growth in 2025.

Javier Hasse High Times revival marks a new era in cannabis journalism, blending tradition, activism, and cultural innovation.

Israel Tree Sector grows globally with medical innovation while facing scrutiny over human rights, politics, and accountability.

Trump CBD Medicare proposal sparks debate over access, Big Pharma control, and the future of federal cannabis reform.

Michigan 24% Tree Tax sparks outrage amid fraud probes and debate over foreign aid, state spending, and local accountability.

Roger Volodarsky Puffco shows courage and conscience, standing for human rights while redefining cannabis activism and leadership.

Mark Kazinec, Cuban-Jewish entrepreneur and cannabis pioneer, redefines culture and innovation through Best in Grass.

Michigan’s new 24% cannabis tax sparks backlash amid $5B fraud probe and growing scrutiny of the state’s financial oversight.